CPT 82553: Creatine Kinase MB Isoenzyme Assay

CPT code 82553 represents a laboratory assay for the MB fraction of creatine kinase (CK-MB), an enzyme fraction commonly measured when myocardial injury is suspected. As a targeted cardiac biomarker test, CK-MB has clinical relevance for detecting and timing cardiac muscle damage, complementing other biomarkers used in acute care. Nationally, CK-MB testing remains part of cardiac diagnostic workflows in many hospitals and outpatient laboratories, influencing laboratory utilization, reporting, and reimbursement policy considerations.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for CK-MB testing, the typical service setting where CPT code 82553 is billed, and the common billing modifiers associated with laboratory services. The publication outlines benchmarking and coverage context for major national payers, notes typical sites of service, and summarizes how CPT code 82553 fits within cardiac diagnostic test panels.

This summary provides clinicians, laboratory managers, and billing professionals with concise context on when CPT code 82553 is used, the service environments where it is performed, and the payer landscape relevant to national billing and policy considerations. Data not available in the input include specific payer coverage policies, pricing benchmarks, and related ICD-10 codes.

Billing Code Overview

CPT code 82553 describes a laboratory measurement of the MB isoenzyme fraction of creatine kinase (CK-MB), also known as creatine phosphokinase. The test quantifies the amount of the MB isoenzyme in a patient specimen to help evaluate tissue injury, particularly cardiac muscle damage.

Service Type: Laboratory diagnostic assay — CK isoenzyme fraction (MB only)

Typical Site of Service: Clinical laboratory, hospital laboratory, or outpatient phlebotomy/collection site

Clinical Context

A typical patient is an adult presenting to the emergency department or outpatient clinic with chest pain, shortness of breath, or other symptoms concerning for acute myocardial injury. A clinician orders the CK-MB assay to help evaluate myocardial damage when troponin results are equivocal, unavailable, or in specific clinical scenarios such as recent chest trauma or suspected reinfarction. Blood is collected via venipuncture; the specimen is sent to the clinical laboratory where a medical technologist or automated analyzer measures the CK-MB isoenzyme fraction. Results are returned to the ordering provider and interpreted in the context of clinical presentation, ECG findings, and other cardiac biomarkers. Typical sites of service include hospital inpatient units, emergency departments, and outpatient laboratories or ambulatory care centers.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the physician interpretation portion if the laboratory and professional components are split.
`TC`	Technical component	Use when billing only the laboratory technical component (machine, technician, supplies).

Taxonomy Code	Specialty	Notes
207RC0000X	Cardiology	Cardiologists order CK-MB when evaluating myocardial injury, especially in complex cases.
208D00000X	Emergency Medicine	Emergency physicians frequently order CK-MB during initial evaluation of chest pain.
208000000X	Family Medicine	Primary care clinicians may order CK-MB in urgent care or outpatient settings when evaluating chest pain.
207L00000X	Internal Medicine	Hospitalists and internists order cardiac enzyme panels during inpatient evaluations.
261QM0800X	Clinical Laboratory	Clinical laboratory directors and pathologists oversee performance and reporting of CK-MB assays.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I21.9`	Acute myocardial infarction, unspecified	CK-MB used historically to detect myocardial necrosis and assess timing of infarction.
`I20.9`	Angina pectoris, unspecified	Ordered when evaluating chest pain to help differentiate ischemic causes.
`R07.9`	Chest pain, unspecified	Symptom code prompting cardiac biomarker evaluation including CK-MB.
`I46.9`	Cardiac arrest, cause unspecified	Used in acute settings to evaluate myocardial injury post-resuscitation.
`S26.0X9A`	Traumatic rupture of heart, initial encounter	CK-MB may be ordered when cardiac muscle injury from trauma is suspected.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80061`	Lipid panel; total cholesterol, HDL, and triglycerides with calculation of VLDL and LDL, when performed	Often ordered as part of cardiovascular risk assessment in patients undergoing cardiac workup.
`84484`	Troponin, quantitative	Primary cardiac biomarker used to detect myocardial injury; commonly ordered instead of or alongside CK-MB.
`81025`	Urine pregnancy test, by visual color comparison methods	Ordered for women of childbearing potential prior to certain interventions or imaging in chest pain workup.
`80053`	Comprehensive metabolic panel	Frequently ordered to assess electrolytes, renal and hepatic function in patients with suspected cardiac events.
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Performed alongside CK-MB testing for evaluation of acute coronary syndromes.

OpenPayer

Summary & Overview